
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[MRNA] Moderna Inc - Other Non-Current Liabilities
Data updated 2023-Sep-23 (Saturday)Note: Detailed Statistics for Other Non-Current Liabilities in Balance Sheet for Moderna Inc [NASDAQ:MRNA] with frequency distribution chart that analyze trends & history . Other Non-Current Liabilities include Deferred Taxes, Provisions for Risks etc. View Balance Sheet for broader context
Share
Quarterly Other Non-Current Liabilities values for Moderna Inc are rounded to enhance readability
2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | |
---|---|---|---|---|---|---|
Other Non-Current Liabilities | 865 M | 836 M | 1.04 B | 256 M | 518 M | 555 M |
Sequential Quarter Growth | +3.5% | -19.4% | +305.1% | -50.6% | -6.7% | -37.7% |
Quarter-on Quarter Growth | +67.0% | +50.6% | +16.4% | -48.7% | +194.3% | +206.6% |
Annual Other Non-Current Liabilities values for Moderna Inc are rounded to enhance readability
2022-Dec | 2022-Jan | 2021-Jan | 2020-Jan | 2019-Jan | 2018-Jan | |
---|---|---|---|---|---|---|
Other Non-Current Liabilities | 1.04 B | 808 M | 891 M | 179 M | 140 M | 176 M |
Year-on-Year Growth | +28.3% | -9.3% | +397.8% | +27.9% | -20.5% | -55.9% |
2-yr CAGR | +7.9% | +112.5% | +152.3% | +0.8% | -40.8% | |
3-yr CAGR | +79.6% | +79.4% | +71.7% | -23.4% | ||
4-yr CAGR | +65.0% | +46.4% | +22.2% | |||
5-yr CAGR | +42.6% | +15.2% |
Frequency distribution of quarterly Other Non-Current Liabilities values from 2017-Dec-31 grouped into buckets. Latest Other Non-Current Liabilities value is 865 Million as of 2023-Jun-30
Subsequent stock performance post earnings date till next announcement for Moderna Inc mapped with quarterly Other Non-Current Liabilities values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Other Non-Current Liabilities above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Moderna Inc with subsequent post-earnings performance given Other Non-Current Liabilities values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
Other Non-Current Liabilities - Low | 31% | 69% |
Other Non-Current Liabilities - Medium | 53% | 47% |
Other Non-Current Liabilities - High | 85% | 15% |
Other Non-Current Liabilities (Sequential growth %) - Low | 45% | 55% |
Other Non-Current Liabilities (Sequential growth %) - Medium | 53% | 47% |
Other Non-Current Liabilities (Sequential growth %) - High | 69% | 31% |
Other Non-Current Liabilities (QoQ growth %) - Low | 36% | 64% |
Other Non-Current Liabilities (QoQ growth %) - Medium | 43% | 57% |
Other Non-Current Liabilities (QoQ growth %) - High | 82% | 18% |
Related to Moderna Inc
Information for Moderna Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jun-05 on Google
SEC Reports : Quarterly reports around 2025-Jun-05 on SEC Edgar
Compare Moderna Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Moderna Inc
Industry : Biotechnology industry performance which includes Moderna Inc